These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2404085)

  • 41. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
    Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
    Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
    Ferguson A; Egerszegi P; Bevan DR
    Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB; Walker SC; Fontenot JP
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse reactions and interactions of the neuromuscular blocking drugs.
    Ostergaard D; Engbaek J; Viby-Mogensen J
    Med Toxicol Adverse Drug Exp; 1989; 4(5):351-68. PubMed ID: 2682131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
    Bevan JC; Collins L; Fowler C; Kahwaji R; Rosen HD; Smith MF; de Scheepers LD; Stephenson CA; Bevan DR
    Anesth Analg; 1999 Aug; 89(2):333-9. PubMed ID: 10439743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications.
    McLean DJ; Diaz-Gil D; Farhan HN; Ladha KS; Kurth T; Eikermann M
    Anesthesiology; 2015 Jun; 122(6):1201-13. PubMed ID: 25919486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.
    Fuchs-Buder T; Baumann C; De Guis J; Guerci P; Meistelman C
    Eur J Anaesthesiol; 2013 Oct; 30(10):594-8. PubMed ID: 23803594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical comparison of atracurium and vecuronium (Org NC 45).
    Robertson EN; Booij LH; Fragen RJ; Crul JF
    Br J Anaesth; 1983 Feb; 55(2):125-9. PubMed ID: 6131682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal anesthetic regimen for ambulatory laser microlaryngeal surgery.
    Huh H; Park SJ; Lim HH; Jung KY; Baek SK; Yoon SZ; Lee HW; Lim HJ; Cho JE
    Laryngoscope; 2017 May; 127(5):1135-1139. PubMed ID: 27796041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Belmont MR; Lien CA; Quessy S; Abou-Donia MM; Abalos A; Eppich L; Savarese JJ
    Anesthesiology; 1995 May; 82(5):1139-45. PubMed ID: 7741288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selecting neuromuscular-blocking drugs for elderly patients.
    Cope TM; Hunter JM
    Drugs Aging; 2003; 20(2):125-40. PubMed ID: 12534313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between train-of-four ratio and first-twitch depression during neuromuscular blockade: a pharmacokinetic/dynamic explanation.
    Bartkowski RR; Epstein RH
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):335-46. PubMed ID: 2231323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A two-center study evaluating the hemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in patients undergoing coronary artery bypass surgery.
    Searle NR; Thomson I; Dupont C; Cannon JE; Roy M; Rosenbloom M; Gagnon L; Carrier M
    J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):20-5. PubMed ID: 10069278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Muscle relaxants in ambulatory anesthesia].
    Takeda J
    Masui; 2008 Jul; 57(7):845-52. PubMed ID: 18649639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular and autonomic nervous effects of edrophonium and atropine combinations during neuromuscular blockade antagonism in sheep.
    Clutton RE; Glasby MA
    Vet Anaesth Analg; 2008 May; 35(3):191-200. PubMed ID: 18282258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
    Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG
    Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of halothane, enflurane and isoflurane on the pharmacodynamics of mivacurium in children].
    Neidhart G; Pabelick C; Kuhn I; Leuwer M; Vettermann J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):293-7. PubMed ID: 8767242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.